Global Challenges in Cardiovascular Prevention in Populations with Low Socioeconomic Status
38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
19 °P sammeln
  • Gebundenes Buch

Cardiovascular Prevention (CVP) has included important technological advances and determined improvements in morbidity and mortality since the last 70 and 60 years. However, in populations with socioeconomic limited resources even basic health preserving tools such as access to a primary care provider and basic drug therapy for diabetes mellitus, high blood pressure, and high cholesterol are not within the reach of many. There is indeed limited information on the level of CVP available in low-income countries and even in similar segments of deprived populations from high income nations. More…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cardiovascular Prevention (CVP) has included important technological advances and determined improvements in morbidity and mortality since the last 70 and 60 years. However, in populations with socioeconomic limited resources even basic health preserving tools such as access to a primary care provider and basic drug therapy for diabetes mellitus, high blood pressure, and high cholesterol are not within the reach of many. There is indeed limited information on the level of CVP available in low-income countries and even in similar segments of deprived populations from high income nations. More information is needed in the prevalence and outcomes in these socioeconomic groups on the major determinants of cardiovascular disease and death: hypertension, diabetes, obesity, heart failure, coronary heart disease, stroke, peripheral vascular disease, and multi-organ involvement. Moreover, in many countries (and not only in those with limited socioeconomic resources) basic preventive measures are still lagging behind (weight control, healthy diet, sedentary lifestyles, smoking cessation, alcohol use). In this book, contributors will review the prevalence of these risk factors as well as discuss possible remedial measures.

In the different chapters, scientists from different countries and regions and with extensive research done in CVP in their respective fields will give their views on the status of CVP and suggest feasible remedial steps. Currently, there are many publications on the exciting and more recent developments in CVP, and the new directions undertaken (polygenic risk scores, primordial prevention, new antilipidemic and anti-inflammatory therapies, etc.). This book, in contrast, will go precisely in the opposite direction, defining the most basic and known effective CVP tools applied in the largest segment of the world's population.

This will be a valuable resource for students and professionals from different specialties, such as primary care providers, cardiologists, registered nurses, public health professionals, social workers, and economists. It will also be of interest to readers in the graduate and undergraduate levels. To ensure broad accessibility, an open access option is available for those with limited financial resources.
Autorenporträt
Tomás Romero graduated from the University of Chile, School of Medicine. He completed residencies in Internal Medicine and Cardiology at San Borja Hospital (Chairman Prof Francisco Rojas Villegas), Faculty of Medicine, University of Chile, and a Cardiology Fellowship at the University of California, San Diego, California (Chairman Professor Eugene Braunwald). He has the following American Boards Certification: American College of Physicians, American College of Cardiology, American Society of Cardiac Angiography and Interventions. He has been elected a Fellow of the American Heart Association (Emeritus), American College of Cardiology (Emeritus), American College of Physicians, American Society of Cardiac Angiography and Interventions.  He has affiliations to the following San Diego Healthcare Centers: Associate Clinical Professor, University of California, San Diego School of Medicine, Sharp Health Care, and Scripps Health Care. Past Chief of Cardiology, Sharp Chula Vista Medical Center; Past Review Board Member, Sharp Health Care; President of the Fundación Araucaria Foundation, San Diego, California. Honorary Member of Chilean Society of Cardiology and Cardiovascular Surgery. He has published or sponsored through Fundación Araucaria Foundation more than 200 research contributions on the subject of coronary artery disease, hypertension, cardiovascular risk factors, cardiovascular prevention and rehabilitation, most of them published or presented in international journals or scientific sessions. Carolina Nazzal Nazal received her PhD in Public Health from the University of Chile in 2013. She has been an Associate Professor at the University of Chile in the Epidemiology Programme since 2005. Her research focuses on cardiovascular disease and its social determinants, with a long research on coronary heart disease in women, vulnerable populations, and evaluation of public policies in cardiovascular disease. Currently she has also incorporated environmental factors such as climate change in the study of risk factors associated with cardiovascular disease that mainly affects the most vulnerable regions. She is author or co-author of more than 70 publications in national and international journals, as well as author of numerous research papers presented at national and international cardiology congresses. She is a consultant on cardiovascular issues for the Chilean Ministry of Health and a member of the Council on Cardiopathy in Women of the Interamerican Society of Cardiology. Fernando Lanas, MD, graduated from the University of Chile School of Medicine. He completed a residency in Internal Medicine at Universidad de Chile and was a Cardiology Fellow at the University of Miami, Jackson Memorial Hospital. He obtained a Master's Degree from the University of Pennsylvania in Clinical Epidemiology and a PhD from Universidad Autónoma de Barcelona in Biomedical Research and Public Health. He is a full professor of medicine at Universidad de La Frontera, where he was the chair of the cardiology unit and director of the internal medicine department. He is a fellow of ACC, ESC, and SIAC. His research interests are risk factors and therapy for cardiovascular diseases. He has 340 ISI publications. He was president of the Chilean Society of Cardiology and the Chilean Society of Hypertension, Vice-President of the InterAmerican Society of Cardiology, and a member of the Scientific Committee of the World Heart Federation. He has been an advisor for the Chilean Ministry of Health PAHO and WHO, and he is a member of the Chilean Academy of Sciences of the Chilean Institute.